Patents-Review.com
ClassID:

20270 ⎘

A61K31/277 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Nitriles; Isonitriles having a ring, e.g. verapamil

Recent Application in this class:
#301
20220064157
2022-03-03

High penetration drugs and their compositions thereof for treatment of Parkinson diseases

 #302
20220062372
2022-03-03

METHODS FOR TREATING DISEASE AND REDUCING DRUG-INDUCED LIVER INJURY IN PATIENT POPULATIONS

 #303
20220062230
2022-03-03

Substituted benzothiophene analogs as selective estrogen receptor degraders

 #304
20220054500
2022-02-24

Inhibition of thymine DNA glycosylase in the treatment of cancer

 #305
20220048979
2022-02-17

Treatment of staphylococcal disorders

 #306
20220048881
2022-02-17

TRICYCLIC SPIRO COMPOUND

 #307
20220047540
2022-02-17

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

 #308
20220040252
2022-02-10

TREATMENT OF PROSTATE CANCER BY ANDROGEN ABLATION AND IL-8 BLOCKADE

 #309
20220040139
2022-02-10

HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF

 #310
20220040138
2022-02-10

Teriflunomide topical pharmaceutical compositions

 #311
20220040126
2022-02-10

Methods and compositions for the treatment of cytoplasmic glycogen storage disorders

 #312
20220023264
2022-01-27

Compositions and methods for treating neuropsychiatric disorders

 #313
20220016106
2022-01-20

COMPOUNDS AND METHODS USEFUL FOR TREATING OR PREVENTING HEMATOLOGICAL CANCERS

 #314
20220016046
2022-01-20

PERMANENTLY CHARGED SODIUM AND CALCIUM CHANNEL BLOCKERS AS ANTI-INFLAMMATORY AGENTS

 #315
20220008396
2022-01-13

Compositions and methods for treating neuropsychiatric disorders

 #316
20220008370
2022-01-13

Systems and Methods Involving Non-Surgical Laser Treatment of a Fibrous Mass

 #317
20220000830
2022-01-06

Solid forms of selective androgen receptor modulators

 #318
20220000794
2022-01-06

TRANSDERMAL PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF MULTIPLE SCLEROSIS

 #319
20210401847
2021-12-30

Medicaments containing riboflavin exhibiting improved flowability

 #320
20210379062
2021-12-09

The use of a H3R inverse agonist for the treatment of excessive daytime sleepiness associated with parkinson's disease (PD)

 #321
20210361578
2021-11-25

MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION

 #322
20210355156
2021-11-18

2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof

 #323
20210353610
2021-11-18

SMALL MOLECULE MENIN INHIBITORS

 #324
20210353599
2021-11-18

Use of HIF-2α inhibitors for treating chondrosarcoma, or preventing recurrence and metastasis thereof

 #325
20210347749
2021-11-11

P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same

 #326
20210346394
2021-11-11

Remyelination Therapy

 #327
20210338839
2021-11-04

COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY

 #328
20210338682
2021-11-04

METHOD OF TREATING PATIENTS COADMINISTERED A FACTOR Xa INHIBITOR AND VERAPAMIL

 #329
20210330737
2021-10-28

Treatment of rhinosinusitis with p-glycoprotein inhibitors

 #330
20210330634
2021-10-28

Treatment of circadian rhythm disorders

 #331
20210330631
2021-10-28

FORMULATION OF CALCIUM CHANNEL BLOCKERS FOR TREATMENT OF SARS-COV-2 INDUCED COVID-19 AND OTHER RESPIRATORY VIRUSES THROUGH PULMONARY DELIVERY

 #332
20210322395
2021-10-21

METHOD TO PREVENT AND TREAT HEARING LOSS BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

 #333
20210317079
2021-10-14

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α

 #334
20210315856
2021-10-14

PROTEIN-PROTEIN INTERACTION INDUCING TECHNOLOGY

 #335
20210315855
2021-10-14

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #336
20210315838
2021-10-14

SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION

 #337
20210299253
2021-09-30

AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same

 #338
20210299207
2021-09-30

Systems, methods, and kits for diagnostics and treatment of viral respiratory infection

 #339
20210299118
2021-09-30

Coordinated metabolic reprogramming in response to productive viral infections

 #340
20210299070
2021-09-30

METHODS OF TREATING CREATINE TRANSPORTER DEFICIENCY

 #341
20210299038
2021-09-30

METHOD TO PREVENT AND TREAT OCULAR CATARACT BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

 #342
20210293824
2021-09-23

Preeclampsia biomarkers and related systems and methods

 #343
20210290920
2021-09-23

Implantable drug delivery devices for localized drug delivery

 #344
20210290607
2021-09-23

Method to prevent and treat macular degeneration by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers

 #345
20210290585
2021-09-23

METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH CORTICO-HIPPOCAMPAL HYPERACTIVITY

 #346
20210290584
2021-09-23

Implantable drug delivery devices for localized drug delivery

 #347
20210290561
2021-09-23

PERMANENTLY CHARGED SODIUM AND CALCIUM CHANNEL BLOCKERS AS ANTI-INFLAMMATORY AGENTS

 #348
20210283147
2021-09-16

17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure

 #349
20210283091
2021-09-16

DECREASING IMMUNE ACTIVITY THROUGH MODULATION OF POSTCELLULAR SIGNALING FACTORS

 #350
20210261594
2021-08-26

USE OF AVERMECTIN DERIVATIVE FOR INCREASING BIOAVAILABILITY AND EFFICACY OF MACROCYLIC LACTONES

 #351
20210260200
2021-08-26

Bifunctional molecules for targeting Rpn11

 #352
20210252036
2021-08-19

METHODS OF TREATING CANCER BY INHIBITING UBIQUITIN CONJUGATING ENZYME E2 K (UBE2K)

 #353
20210251922
2021-08-19

Methods and compositions for the treatment of steatosis-associated disorders

 #354
20210244693
2021-08-12

Non-surgical laser treatment for a fibrous mass

 #355
20210230176
2021-07-29

Hepatitis B antiviral agents

 #356
20210228529
2021-07-29

PHARMACEUTICAL COMPOSITIONS FOR TREATING BREAST CANCERS AND METHODS OF USES THEREOF

 #357
20210220408
2021-07-22

ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE

 #358
20210205261
2021-07-08

Treatment of circadian rhythm disorders

 #359
20210205258
2021-07-08

HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF

 #360
20210196710
2021-07-01

Compounds and methods for the targeted degradation of androgen receptor

 #361
20210196678
2021-07-01

SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF

 #362
20210196667
2021-07-01

Estrogen receptor ligands, compositions and methods related thereto

 #363
20210186957
2021-06-24

Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same

 #364
20210186918
2021-06-24

METHODS AND COMPOSITIONS FOR TREATING OBESITY, PREVENTING WEIGHT GAIN, PROMOTING WEIGHT LOSS, PROMOTING SLIMMING, OR TREATING OR PREVENTING THE DEVELOPMENT OF DIABETES

 #365
20210186917
2021-06-24

TREM2 AGONISTS FOR THE STIMULATION OF MICROGLIA AND METHODS OF IDENTIFICATION

 #366
20210177758
2021-06-17

Platform drug delivery system utilizing crystal engineering and theanine dissolution

 #367
20210171470
2021-06-10

Compounds and methods for the targeted degradation of androgen receptor

 #368
20210169984
2021-06-10

SENSITIZING CANCER TO DEATH RECEPTOR AGONISTS WITH KINASE INHIBITORS

 #369
20210169920
2021-06-10

Compositions and methods of modulating HIF-2A to improve muscle generation and repair

 #370
20210163399
2021-06-03

NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING PROTEINOPATHIES COMPRING THE SAME

 #371
20210161919
2021-06-03

Metakaryocidal Treatments

 #372
20210161868
2021-06-03

ANTI-INFLAMMATORY THERAPY IN ARRHYTHMOGENIC CARDIOMYOPATHY (ACM)

 #373
20210161854
2021-06-03

Treatment of circadian rhythm disorders

 #374
20210161837
2021-06-03

METHODS FOR TREATING CANCER WITH RORGAMMA INHIBITORS

 #375
20210161836
2021-06-03

Treatment of demyelinating disorders

 #376
20210154165
2021-05-27

Targeting of ARID1A-deficient cancers by inhibiting de novo pyrimidine synthesis pathway

 #377
20210137866
2021-05-13

Use of CYP26-resistant RAR alpha selective agonists in the treatment of cancer

 #378
20210137865
2021-05-13

USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER

 #379
20210137833
2021-05-13

Dental topical anesthetic gel

 #380
20210128517
2021-05-06

TREATMENT OF CIRCADIAN RHYTHM DISORDERS

 #381
20210128514
2021-05-06

METHOD AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF BROAD SPECTRUM VIRUS AILMENTS COMPRISING A CALCIUM CHANNEL BLOCKER OR A CALMODULIN BLOCKER

 #382
20210128513
2021-05-06

Treatment of skeletal-related events for breast cancer patients

 #383
20210128498
2021-05-06

Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide

 #384
20210122730
2021-04-29

GLUCOCORTICOID RECEPTOR MODULATORS

 #385
20210113521
2021-04-22

Methods of treating Prader-Willi syndrome

 #386
20210094904
2021-04-01

POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS

 #387
20210093605
2021-04-01

METHODS FOR TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS

 #388
20210093604
2021-04-01

METHOD OF TREATING PATIENTS WITH A FACTOR Xa INHIBITOR, ASPIRIN, AND VERAPAMIL

 #389
20210093560
2021-04-01

METHOD FOR TREATMENT OF PARKINSON'S DISEASE

 #390
20210088520
2021-03-25

TREATMENT OF TUMORS INCORPORATING MUTANT ISOCITRATE DEHYDROGENASE

 #391
20210085635
2021-03-25

Use of levodopa, carbidopa and entacapone for treating Parkinson's disease

 #392
20210077442
2021-03-18

Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same

 #393
20210069296
2021-03-11

Treatment of pyroptosis

 #394
20210069164
2021-03-11

Compositions and methods for treatment of edema

 #395
20210069126
2021-03-11

Intranasal Formulation of Epinephrine for the Treatment of Anaphylaxis

 #396
20210069108
2021-03-11

METHODS FOR PREVENTION AND TREATMENT OF PRESSURE ULCERS CAUSED BY ISCHEMIA USING CONTACT VASODILATORS

 #397
20210069102
2021-03-11

METHODS FOR PREVENTION AND TREATMENT OF UROGENITAL ATROPHY OF MENOPAUSE BY CONTACT VASODILATORS

 #398
20210059972
2021-03-04

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #399
20210052585
2021-02-25

Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same

 #400
20210052519
2021-02-25

Small molecule drugs and related methods for treatment of diseases related to TDP-43, alpha-synuclein, huntingtin's protein and tau protein oligomer formation

 #401
20210052514
2021-02-25

Immunomodulator compounds

 #402
20210040044
2021-02-11

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

 #403
20210032198
2021-02-04

Compounds for use as inhibitors of alternative oxidase or cytochrome bc1 complex

 #404
20210030710
2021-02-04

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

 #405
20210030695
2021-02-04

PERMANENTLY CHARGED SODIUM AND CALCIUM CHANNEL BLOCKERS AS ANTI-INFLAMMATORY AGENTS

 #406
20210023033
2021-01-28

Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof

 #407
20210015785
2021-01-21

Combination of a ubiquitin-conjugating enzyme complex inhibitor and antihypertensive and/or hypoglycemic drugs in diabetic kidney disease

 #408
20210015782
2021-01-21

Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders

 #409
20210015764
2021-01-21

METHODS OF REDUCING INFLAMMATION OF THE DIGESTIVE SYSTEM WITH INHIBITORS OF HIF-2- ALPHA

 #410
20210009528
2021-01-14

Compounds and methods for the targeted degradation of androgen receptor

 #411
20210000972
2021-01-07

NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE

 #412
20200397770
2020-12-24

Compositions for the treatment of hypertension

 #413
20200397730
2020-12-24

Continuous Administration of L-Dopa, Dopa Decarboxylase Inhibitors, Catechol-O-Methyl Transferase Inhibitors and Compositions for Same

 #414
20200390740
2020-12-17

Methods and pharmaceutical compositions for treating microbiome dysregulations associated with circadian clock disruption

 #415
20200390698
2020-12-17

URETHRAL DEVICES FOR TREATMENT OF PATHOLOGICAL UROLOGICAL CONDITIONS

 #416
20200384062
2020-12-10

USE OF INHIBITORS OF IL-36 PROTEOLYTIC PROCESSING FOR THE TREATMENT AND/OR REDUCTION OF INFLAMMATION

 #417
20200368352
2020-11-26

POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG UNCAGING

 #418
20200368195
2020-11-26

HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF

 #419
20200360381
2020-11-19

COMPOUNDS FOR TREATING DENGUE VIRUS INFECTION AND OTHER VIRAL INFECTIONS

 #420
20200352898
2020-11-12

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

 #421
20200345700
2020-11-05

LSD1 inhibitor and preparation method and application thereof

 #422
20200338157
2020-10-29

Compositions and methods for the treatment of fungal infections

 #423
20200338036
2020-10-29

Methods and compositions for increasing the potency of antifungal agents

 #424
20200333358
2020-10-22

METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS

 #425
20200331847
2020-10-22

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

 #426
20200308109
2020-10-01

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

 #427
20200306371
2020-10-01

Methods for treating breast cancer using INOS-inhibitory compositions

 #428
20200299243
2020-09-24

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

 #429
20200270200
2020-08-27

Deuterated compounds and uses thereof

 #430
20200268719
2020-08-27

Activator of peroxisome proliferator-activated receptor

 #431
20200268696
2020-08-27

Non-surgical laser treatment for a fibrous mass

 #432
20200264188
2020-08-20

PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS

 #433
20200261469
2020-08-20

Mitofusin activators and uses thereof

 #434
20200246365
2020-08-06

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE

 #435
20200237635
2020-07-30

Methods for treating hair loss disorders

 #436
20200230097
2020-07-23

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #437
20200222333
2020-07-16

MESOSCALE NANOPARTICLES FOR SELECTIVE TARGETING TO THE KIDNEY AND METHODS OF THEIR THERAPEUTIC USE

 #438
20200215053
2020-07-09

ABUSE-PROOFED DOSAGE FORM

 #439
20200215038
2020-07-09

INHIBITORS OF DIHYDROOROTATE DEHYDROGENASE

 #440
20200215023
2020-07-09

Prevention of rosacea inflammation

 #441
20200199143
2020-06-25

Hepatitis B antiviral agents

 #442
20200197481
2020-06-25

Treatment of rhinosinusitis with P-glycoprotein inhibitors

 #443
20200188407
2020-06-18

Compounds and methods for inducing chondrogenesis

 #444
20200181115
2020-06-11

Method for preparing 2-hydroxyl-4-(2, 3-disubstituted benzyloxy)-5-substituted benzaldehyde derivative

 #445
20200179326
2020-06-11

Treatment of circadian rhythm disorders

 #446
20200179324
2020-06-11

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

 #447
20200171016
2020-06-04

Multi-targeting agents for Alzheimer's disease therapy

 #448
20200163918
2020-05-28

POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS

 #449
20200163896
2020-05-28

FLOATABLE PHARMACEUTICAL MICROCAPSULE COMPOSITION

 #450
20200155493
2020-05-21

Pharmaceutical composition for treating excessive lactate production and acidemia

 #451
20200155483
2020-05-21

COMBINATION THERAPY FOR THE TREATMENT OF TINNITUS AND OTHER MEDICAL CONDITIONS

 #452
20200140754
2020-05-07

Singlet oxygen scavenger

 #453
20200129637
2020-04-30

COMBINATION THERAPY WITH AN ANTI-AXL ANTIBODY-DRUG CONJUGATE

 #454
20200129586
2020-04-30

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ADRENOCORTICAL ACTIVITY AND/OR EXCESSIVE STEROID PRODUCTION

 #455
20200123271
2020-04-23

COMPOSITION FOR ENHANCING SENSITIVITY OF PROSTATE CANCER TO ANTICANCER DRUG AND USE THEREOF

 #456
20200121764
2020-04-23

Topical therapeutic formulations

 #457
20200121631
2020-04-23

HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF

 #458
20200113865
2020-04-16

Method of treating patients with a factor Xa inhibitor, aspirin, and verapamil

 #459
20200102284
2020-04-02

Tricyclic spiro compound

 #460
20200101130
2020-04-02

Novel-anti-infective strategy against influenza virus and coinfections

 #461
20200095205
2020-03-26

Compounds and methods for the targeted degradation of androgen receptor

 #462
20200088732
2020-03-19

METHODS FOR THE DIAGNOSIS AND TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA

 #463
20200061027
2020-02-27

Pharmacological restoration of epithelial or endothelial barrier integrity by agents blocking EPAC/RAP1 signaling

 #464
20200057076
2020-02-20

Methods of treating patients at risk for renal injury and renal failure

 #465
20200055825
2020-02-20

Compounds and methods for the targeted degradation of androgen receptor

 #466
20200055819
2020-02-20

Nicotinyl alcohol ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof

 #467
20200046741
2020-02-13

SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAME

 #468
20200046734
2020-02-13

Methods of Reducing Mammographic Breast Density and/or Breast Cancer Risk

 #469
20200046673
2020-02-13

Method of treating patients with a factor Xa inhibitor, aspirin, and verapamil

 #470
20200041516
2020-02-06

Treatment of metastatic prostate cancer

 #471
20200030277
2020-01-30

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

 #472
20200016265
2020-01-16

iNOS-INHIBITORY COMPOSITIONS FOR TREATING CANCER

 #473
20200016137
2020-01-16

Compositions and methods for treatment of edema

 #474
20200016072
2020-01-16

NRF2 Screening Assays and Related Methods and Compositions

 #475
20200009117
2020-01-09

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS

 #476
20200009112
2020-01-09

Methods and compositions for modulating hormone levels

 #477
20200009106
2020-01-09

Treatment of circadian rhythm disorders

 #478
20200009103
2020-01-09

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

 #479
20190388386
2019-12-26

MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS

 #480
20190380993
2019-12-19

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #481
20190374658
2019-12-12

Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles

 #482
20190365688
2019-12-05

Amide derivative

 #483
20190358246
2019-11-28

Metakaryocidal Treatments

 #484
20190352265
2019-11-21

Aryl isonitriles as a new class of antimicrobial compounds

 #485
20190352264
2019-11-21

Aryl isonitriles as a new class of antimicrobial compounds

 #486
20190350891
2019-11-21

Methods for treatment of infections

 #487
20190343827
2019-11-14

DEUTERATED ANALOGS OF TARIQUIDAR

 #488
20190343818
2019-11-14

Compositions for the treatment of hypertension

 #489
20190336468
2019-11-07

METHODS AND COMPOSITIONS FOR THE TREATMENT OF MULTIPLE SCLEROSIS

 #490
20190330154
2019-10-31

Aryl isonitriles as a new class of antimicrobial compounds

 #491
20190321388
2019-10-24

Pharmaceutical compositions and methods for potentiating gene silencing

 #492
20190321358
2019-10-24

ABUSE-PROOFED DOSAGE FORM

 #493
20190321333
2019-10-24

Carboxamide derivative and its diastereomers in stable crystalline form

 #494
20190321327
2019-10-24

METHOD OF TREATING HYPERGLYCEMIA

 #495
20190321326
2019-10-24

Method of treating hyperglycemia

 #496
20190307721
2019-10-10

MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS

 #497
20190298686
2019-10-03

Methods of treating Prader-Willi syndrome

 #498
20190282535
2019-09-19

Combination therapy of a HIF-2-α inhibitor and an immunotherapeutic agent and uses thereof

 #499
20190274992
2019-09-12

Method and compositions for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker

 #500
20190269644
2019-09-05

Methods and compositions for treating disorders associated with cortico-hippocampal hyperactivity

 #501
20190269643
2019-09-05

HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF

 #502
20190262250
2019-08-29

Methods for treating hair loss disorders

 #503
20190255013
2019-08-22

Combination comprising EP4 antagonist and immune checkpoint inhibitor

 #504
20190255009
2019-08-22

Stilbene derivative and method for preparing same

 #505
20190248729
2019-08-15

Stilbene derivative and method for preparing same

 #506
20190247309
2019-08-15

SELF-EMULSIFYING LIPID COMPOSITIONS

 #507
20190241531
2019-08-08

Benzyl phenyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof

 #508
20190241506
2019-08-08

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

 #509
20190241505
2019-08-08

(Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide tablet formulations with improved stability

 #510
20190233405
2019-08-01

Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof

 #511
20190231778
2019-08-01

Methods and compositions for treating cancer

 #512
20190231724
2019-08-01

Therapeutic agent for glaucoma

 #513
20190216747
2019-07-18

Permanently charged sodium and calcium channel blockers as anti-inflammatory agents

 #514
20190209592
2019-07-11

BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS

 #515
20190201396
2019-07-04

Treatment of cancers having alterations within the SWI/SNF chromatin remodeling complex

 #516
20190192501
2019-06-27

METHODS FOR TREATING PTEN-MUTANT TUMORS

 #517
20190192476
2019-06-27

Estrogen receptor ligands, compositions and methods related thereto

 #518
20190192475
2019-06-27

4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS

 #519
20190183842
2019-06-20

Entacapone-related compounds to treat macular degeneration

 #520
20190177271
2019-06-13

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

 #521
20190175546
2019-06-13

Mast cell stabilizers treatment for systemic disorders

 #522
20190169122
2019-06-06

Compositions and methods for treatment of prostate carcinoma

 #523
20190167693
2019-06-06

METHOD OF TREATING PATIENTS COADMINISTERED A FACTOR Xa INHIBITOR AND VERAPAMIL

 #524
20190166843
2019-06-06

Pesticidal active mixtures comprising isoxazoline compounds I

 #525
20190151405
2019-05-23

Compositions and methods for the treatment of fungal infections

 #526
20190151347
2019-05-23

Compositions and methods of modulating HIF-2A to improve muscle generation and repair

 #527
20190151320
2019-05-23

APPLICATION OF MAPK SIGNALING PATHWAY INHIBITOR IN MANUFACTURE OF DRUGS FOR DELAYING DEGENERATION OF DOPAMINERGIC NEURONS

 #528
20190144450
2019-05-16

Modulators of ATP-binding cassette transporters

 #529
20190144416
2019-05-16

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

 #530
20190142839
2019-05-16

METHOD OF TREATING PATIENTS COADMINISTERED A FACTOR Xa INHIBITOR AND VERAPAMIL

 #531
20190142781
2019-05-16

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #532
20190142780
2019-05-16

Use of isothiocyanate compounds

 #533
20190133991
2019-05-09

Treatment of circadian rhythm disorders

 #534
20190125716
2019-05-02

Non-invasive method of evaluating breast cancers for selective androgen receptor modulator (SARM) therapy

 #535
20190125715
2019-05-02

CDDO-Me AS A THERAPY FOR LUPUS

 #536
20190125708
2019-05-02

Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same

 #537
20190111010
2019-04-18

Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)

 #538
20190108915
2019-04-11

DISEASE MONITORING FROM INSURANCE CLAIMS DATA

 #539
20190099389
2019-04-04

Methods for inhibiting conversion of choline to trimethylamine (TMA)

 #540
20190092729
2019-03-28

Immunoregulatory agents

 #541
20190091194
2019-03-28

METHODS OF TREATING AND PREVENTING ENDOTHELIAL DYSFUNCTION USING BARDOXOLONE METHYL OR ANALOGS THEREOF

 #542
20190091190
2019-03-28

COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS

 #543
20190086426
2019-03-21

Secreted P-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis

 #544
20190084994
2019-03-21

Hepatitis B antiviral agents

 #545
20190077749
2019-03-14

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

 #546
20190070238
2019-03-07

Simmondsin formulation

 #547
20190070144
2019-03-07

Treatment of circadian rhythm disorders

 #548
20190064161
2019-02-28

OLFR90 specificity and methods of detection

 #549
20190055192
2019-02-21

SELECTIVE ANDROGEN RECEPTOR MODULATOR AND METHODS OF USE THEREOF

 #550
20190046471
2019-02-14

Methods and compositions for the treatment of steatosis-associated disorders

 #551
20190038760
2019-02-07

CO-ADMINISTRATION OF AN AGENT LINKED TO AN INTERNALIZATION PEPTIDE WITH AN ANTI-INFLAMMATORY

 #552
20190029990
2019-01-31

CATECHOL O-METHYLTRANSFERASE ACTIVITY INHIBITING COMPOUNDS

 #553
20190023694
2019-01-24

Broad spectrum antibacterial activity of novel bisbenzimidazoles targeting topoisomerase IA and the synergistic composition of bisbenzimidazole with efflux pump inhibitors against pathogenic bacteria

 #554
20190022048
2019-01-24

HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER AND USES THEREOF

 #555
20190015523
2019-01-17

ELP fusion proteins for controlled and sustained release

 #556
20190015387
2019-01-17

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

 #557
20190010129
2019-01-10

Amide derivatives as lysophosphatidic acid receptor antagonists

 #558
20190008882
2019-01-10

Treatment of autophagy-based disorders and related pharmaceutical compositions, diagnostic and screening assays and kits

 #559
20190008849
2019-01-10

ABUSE-PROOFED DOSAGE FORM

 #560
20190002919
2019-01-03

In Vivo Methods for Enhancing Bioenergetic Status in Female Germ Cells

 #561
20180370905
2018-12-27

Compounds Useful for the Treatment of Metabolic Disorders and Synthesis of the Same

 #562
20180369321
2018-12-27

Compositions and methods for treating conditions related to adrenocortical activity and/or excessive steroid production

 #563
20180369235
2018-12-27

CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS

 #564
20180369186
2018-12-27

METHOD FOR MODULATING AUTOPHAGY AND APPLICATIONS THEREOF

 #565
20180360828
2018-12-20

SHIP1 MODULATORS AND METHODS RELATED THERETO

 #566
20180360783
2018-12-20

Methods and compositions for treatment of demyelinating diseases

 #567
20180353460
2018-12-13

METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs

 #568
20180344732
2018-12-06

METHODS FOR REDUCING THE RISK OF AN ADVERSE TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION IN MULTIPLE SCLEROSIS PATIENTS

 #569
20180338944
2018-11-29

Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof

 #570
20180338943
2018-11-29

POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS

 #571
20180333380
2018-11-22

Use of CYP26-resistant RAR alpha selective agonists in the treatment of cancer

 #572
20180325992
2018-11-15

MODULATION OF AXON DEGENERATION

 #573
20180325858
2018-11-15

METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs

 #574
20180319764
2018-11-08

Tricyclic spiro compound

 #575
20180318381
2018-11-08

Methods of Treatment of Rhabdomyolysis

 #576
20180318380
2018-11-08

Methods of treating muscular dystrophy

 #577
20180318263
2018-11-08

TREATMENT OF PROSTATE CANCER CELLS WITH FAT OXIDATION INHIBITORS AND ENZALUTAMIDE

 #578
20180311256
2018-11-01

METHOD OF TREATING PATIENTS COADMINISTERED A FACTOR Xa INHIBITOR AND VERAPAMIL

 #579
20180306800
2018-10-25

METHODS FOR PREDICTING CANCER PATIENT'S CLINICAL RESPONSE TO ANTI-CANCER COMPOUNDS

 #580
20180303788
2018-10-25

Entacapone for treatment of obesity

 #581
20180303787
2018-10-25

Pharmaceutical use of 3-benzylsulfonylpropionitrile

 #582
20180297939
2018-10-18

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

 #583
20180296510
2018-10-18

Therapeutic neuropathic pain lotion

 #584
20180296500
2018-10-18

Treatment of prostate carcinoma

 #585
20180289728
2018-10-11

EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions

 #586
20180280393
2018-10-04

METHODS AND COMPOSITIONS FOR TREATMENT OF METASTATIC AND REFRACTORY CANCERS AND TUMORS

 #587
20180280355
2018-10-04

Carboxamide derivative and its diastereomers in stable crystalline form

 #588
20180280354
2018-10-04

Carboxamide derivative and its diastereomers in stable crystalline form

 #589
20180280339
2018-10-04

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

 #590
20180273487
2018-09-27

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

 #591
20180273470
2018-09-27

Selective androgen receptor modulator and methods of use thereof

 #592
20180271828
2018-09-27

Mast cell stabilizers treatment for systemic disorders

 #593
20180265536
2018-09-20

Use of avermectin derivative for increasing bioavailability and efficacy of macrocyclic lactones

 #594
20180263970
2018-09-20

Compounds and methods useful for treating or preventing hematological cancers

 #595
20180263963
2018-09-20

Modulators of the adenosine A3 receptors

 #596
20180263959
2018-09-20

Methods of treating muscular dystrophy

 #597
20180263951
2018-09-20

Method of quenching singlet and triplet excited states of photodegradable pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds having electron withdrawing groups, to reduce generation of singlet oxygen

 #598
20180263906
2018-09-20

NRF2 Screening Assays and Related Methods and Compositions

 #599
20180244606
2018-08-30

Farnesoid X receptor agonists and uses thereof

 #600
20180243255
2018-08-30

Anti-cancer agent comprising aminoacetonitrile compound as active ingredient